} People who’ve been injured by Tasigna are eligible to recoup medical costs damages for their suffering, and lost wages.
Contact us to speak with a lawyer about your case at no price.
Tasignas Black Box Warning Links The Drug To Atherosclerosis | 12/15/2017.
Finding a product liability lawyer in your area will allow you to stop worrying as they gather the information and prepare your case for litigation.
You need to find an attorney that is knowledgeable about the product and Tasigna liability laws concerning pharmaceutical cases.
Other Vascular Risks Connected to Tasigna.
April 2013Health Canada issues safety alert for general public and health care professional regarding the risk of developing atherosclerosis-related conditions with the use of Tasigna.
“Nilotinib treatment-associated cerebrovascular disease and stroke.
The Novartis company is the only person who is responsible for marketing and the production of these medication.
How Does Tasigna® Work?
When plaque builds up in the arteries, causing it to harden and narrow the pathways, the disease is.
There was lots of marketing for doctors to prescribe the drug to patients once the current market was reached by Tasigna.
Lawsuit Against Tasigna.
The family members allege that Novartis understood of the dangers that are atherosclerosis Tasigna posed and failed to warn them. . .
” Reuters, 20 Nov.
Life-Threatening Side effects Of Tasigna.
In March 2016, a guy in California who died from a disease related to atherosclerosis after accepting Tasigna’s family filed a wrongful death suit for failing to warn customers.
What Are the Dangers of Atherosclerosis?
Additionally, the lawsuit accused the company of marketing practices that included kickbacks through drug rebates and patient referrals.
Make sure you take your documentation with you and disclose all information regarding the case with the lawyer so they can have all the facts associated with your claim.
The case settled with Novartis.
Among other things, the Tasigna lawsuit claims that Novartis was aware of the potential link to arteriosclerosis but failed to provide patients and physicians with appropriate warnings.
Significantly, lawyer Kelly Slate noted the government retrieval was marked by this case ever.
Tasigna was approved in the USA in 2007.
Novartis International AG, is giant pharmaceutical company from Switzerland responsible for production, producing and marketing of Tasigna, ( generic name: nilotinib) a pharmaceutical drug that’s used as a treatment for chronic myeloid leukemia.
Then, in April of 2013, Novartis, together with officials from Health Canada, warned physicians and patients that carrying Tasigna may increase the risk of atherosclerosis, a thickening of the arteries and precursor to vascular disease.
Since these cases are fought against strong international pharmaceutical companies with teams of lawyers, DrugNews recommends choosing a law firm that specializes in drug injury lawsuit.
10, 2014)–A former Novartis sales manager has filed a whistleblower complaint alleging that the pharmaceutical giant engaged in a massive kickback scheme to unlawfully induce CVS Caremark and other pharmacies to increase sales of five of its patented drugs, even as patients reported severe side effects from the medication.
Consulting Tasigna lawyers will help you to know about your legal rights.
Novartis’ response to competition is Tasigna data.
This causes a condition called peripheral arterial disease (PAD), which is a narrowing of the blood flow space from the arteries.
The Food & Drug Administration (FDA) approved the drug for use in the U.S. in 2007 and since that time, they’ve received thousands of reports of serious issues related to its consumption.
Had the doctor intervened with therapy at the first sign of symptoms, the plaintiff’s life may have been spared.
Novartis Fails To Warn The U.S. Medical Community About The Side Effects of Tasigna | 12/11/2017.
Various studies have alleged that the drug Tasigna has serious undisclosed side effects which include irreversible and life threatening conditions, such as atherosclerosis, that can lead to the following: Allegations suggest that Tasigna causes atherosclerosis, which is a thickening of the arterial walls, narrowing the arteries and building up growth of a fibrofatty plaque, which ultimately can cause peripheral arterial disease (PAD).
Side effects can occur in people taking Tasigna.
Posted in: Health News Tagged in: tasigna.